CDX-2, a New Marker for Adenocarcinoma of Gastrointestinal Origin


    loading  Checking for direct PDF access through Ovid

Abstract

CDX2-88 is a recently developed monoclonal antibody to the intestinal epithelia-specific nuclear transcription factor CDX2. CDX2 immunohistochemistry has recently been shown to be useful in establishing gastrointestinal origin in metastatic tumors and will likely become a useful addition to the standard panel of immunostains for carcinomas of unknown primary sites. This article reviews the previous studies of this new antibody.

    loading  Loading Related Articles